Cfo4 Life Group, LLC Gilead Sciences, Inc. Transaction History

Cfo4 Life Group, LLC

$560 Million
Q3 2024

A detailed history of Cfo4 Life Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cfo4 Life Group, LLC holds 4,153 shares of GILD stock, worth $379,376. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,153

Previous 5,902 29.63%

Holding current value

$379,376

Previous $404,000 13.86%

% of portfolio

0.06%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $116,465 - $146,898	-1,749 Reduced 29.63%	4,153 $348,000
Q2 2024 Jul 31, 2024	BUY	$63.15 - $72.88 $5,241 - $6,049	83 Added 1.43%	5,902 $404,000
Q1 2024 May 06, 2024	SELL	$71.58 - $87.29 $250,673 - $305,689	-3,502 Reduced 37.57%	5,819 $426,000
Q4 2023 Jan 24, 2024	SELL	$73.27 - $83.09 $287,584 - $326,128	-3,925 Reduced 29.63%	9,321 $755,000
Q3 2023 Oct 30, 2023	SELL	$73.94 - $80.67 $106,029 - $115,680	-1,434 Reduced 9.77%	13,246 $992,000
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $265,198 - $302,496	3,489 Added 31.18%	14,680 $1.13 Million
Q1 2023 May 03, 2023	SELL	$77.31 - $88.08 $6,107 - $6,958	-79 Reduced 0.7%	11,191 $928,000
Q4 2022 Feb 03, 2023	SELL	$62.32 - $89.47 $201,231 - $288,898	-3,229 Reduced 22.27%	11,270 $967,000
Q3 2022 Oct 19, 2022	SELL	$59.54 - $68.01 $17,147 - $19,586	-288 Reduced 1.95%	14,499 $894,000
Q2 2022 Jul 20, 2022	BUY	$57.72 - $65.01 $17,431 - $19,633	302 Added 2.08%	14,787 $901,000
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $15,580 - $19,524	-269 Reduced 1.82%	14,485 $861,000
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $957,239 - $1.09 Million	14,754 New	14,754 $1.07 Million
Q3 2020 Oct 13, 2020	SELL	$62.1 - $78.08 $219,275 - $275,700	-3,531 Closed	0 $0
Q2 2020 Jul 15, 2020	SELL	$72.34 - $84.0 $83,408 - $96,852	-1,153 Reduced 24.62%	3,531 $272,000
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $95,698 - $122,576	-1,528 Reduced 24.6%	4,684 $350,000
Q4 2019 Jan 22, 2020	BUY	$61.62 - $67.78 $8,503 - $9,353	138 Added 2.27%	6,212 $404,000
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $2,375 - $2,622	38 Added 0.63%	6,074 $385,000
Q2 2019 Jul 29, 2019	BUY	$61.87 - $69.38 $58,900 - $66,049	952 Added 18.73%	6,036 $408,000
Q1 2019 Apr 22, 2019	SELL	$62.53 - $70.05 $53,650 - $60,102	-858 Reduced 14.44%	5,084 $331,000
Q4 2018 Feb 01, 2019	BUY	$60.54 - $79.0 $1,755 - $2,291	29 Added 0.49%	5,942 $372,000
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $4,989 - $5,524	-70 Reduced 1.17%	5,913 $457,000
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $103,808 - $121,088	-1,600 Reduced 21.1%	5,983 $424,000
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $1,893 - $2,308	26 Added 0.34%	7,583 $572,000
Q4 2017 Jan 22, 2018	SELL	$71.15 - $83.52 $180,578 - $211,973	-2,538 Reduced 25.14%	7,557 $541,000
Q3 2017 Nov 09, 2017	SELL	$72.11 - $85.47 $24,084 - $28,546	-334 Reduced 3.2%	10,095 $818,000
Q2 2017 Aug 08, 2017	BUY	N/A	10,429	10,429 $738,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfo4 Life Group, LLC with notifications on news.

Account

Cfo4 Life Group, LLC Gilead Sciences, Inc. Transaction History